|
|
| | safracin A Basic information |
| Product Name: | safracin A | | Synonyms: | safracin A;2-Amino-N-[(6,7,9,10,13,14,14a,15-octahydro-1-hydroxy-2,11-dimethoxy-3,12,16-trimethyl-10,13-dioxo-6,15-epimino-5H-isoquino[3,2-b][3]benzazocin-9-yl)methyl]propionamide;PubChem ID: 160293;Y-16760 | | CAS: | 87578-98-1 | | MF: | C28H36N4O6 | | MW: | 524.61 | | EINECS: | | | Product Categories: | | | Mol File: | 87578-98-1.mol |  |
| | safracin A Chemical Properties |
| Boiling point | 719.074±60.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.366±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 9.853±0.70(predicted) |
| | safracin A Usage And Synthesis |
| Uses | Safracin A has anti-Gram-positive bacteria, Gram-negative bacteria and anti-tumor effect[1]. | | References | [1] T Okumoto, et al. Activity of safracins A and B, heterocyclic quinone antibiotics, on experimental tumors in mice. J Antibiot (Tokyo). 1985 Jun;38(6):767-71. DOI:10.7164/antibiotics.38.767 |
| | safracin A Preparation Products And Raw materials |
|